2025 Past NextGen Webinars
Recording will be available shortly.
Title: Microcapsules for single-shot vaccination; Romain Guyon, PhD, University of Oxford, UK
Title: From Dopamine to Vaccine – or: What is it that you do at work, son?; Stefan Jungbluth, PhD, MBA, European Vaccine Initiative, Germany
Moderator: Allegra Peletta, PhD,Vaccine Formulation Institute, Switzerland
Recording will be available shortly.
Title: All about microneedle vaccination and the journey of building a vaccine startup; Dr. Koen van der Maaden, Leiden University, the Netherlands
Title: Navigating transitions between academia and industry, and tips for securing fellowships; Dr. Kevin M. Koo, The University of Queensland Centre for Clinical Research (UQCCR), Australia
Moderator: Dr. Sandra Depelsenaire, Vaxxas Pty Ltd
TITLE: COVID-19-related inflammation of the placenta impedes fetal development in pregnant hamsters; Yana Kumpaneko, MD, KU Leuven, Belgium
TITLE: Building a Positive Research Culture; Prof. Dr. Adrian Liston, University of Cambridge, United Kingdom
Title: What could possibly go wrong? Lessons learned the hard way from not thinking about IP early; Dr. Belinda Hartmann, Uniquest Pty Ltd
Title: Developing vaccines using the molecular clamp technology; Dr. Andrew Young, The University of Queensland, Australia
Moderator: Dr. Sandra Depelsenaire, Vaxxas Pty Ltd
Title: Mapping B Cell Precursors in HIV: A Southern African Perspective on Germline-Targeting Vaccine Strategies; Dr. Judie Magura, Africa Health Research Institute (AHRI), South Africa
Title: Being resourceful in an under-resourced research landscape: leveraging optimism and collaboration; Focus: foot and mouth disease virus (FMDV); Dr. Keba Lebani, Botswana International University of Science and Technology, Botswana
Moderator: Dr. Sandra Depelsenaire, Vaxxas Pty Ltd
Recording is not available.
Title: From Pipettes to Pitches: Navigating a Career in Nanomedicine
Speaker: Dr. Martin Rabel, Cytiva
Title:Vaccine adjuvants, delivery systems and immunostimulators
Speaker: Dr. Dennis Christensen, Statens Serum Institut
Recording is not available.
Title: Advancing saRNA Delivery: Evaluating Novel PEI-Inspired Polymers as Non-Viral Carriers; Lisa Opsomer, PhD student, Ghent University
Title: From bench to business development; Dr Wasan Forsyth, Vaxxas Pty Ltd
Title: Exploring Galsomes, adjuvanted mRNA-LNPs, for the development of more effective vaccines against Mycobacterium tuberculosis; Ilke Aernout, Ghent University
TITLE: Longitudinal Assessment of Human Immune Responses to Commercial Influenza Vaccination; Dr. James Allen, Cleveland Clinic
January 2025
TITLE: Improving Humoral Immunogenicity of Adenoviral Vector Vaccines by Capsid Display; Alexander Sampson, Oxford University (Winner of 2024 ISV Annual Congress Bright Sparks Competition)
TITLE: Entrepreneurship and Biotech Start-Up, Dr. Manon Cox, Chief Executive Officer & Co-Founder at NextWaveBio
2024 Past NextGen Webinars
TITLE: Peripheral co delivery of plasmid encoded mucosal chemokine CCL27 enhances mucosal immunity and supports protection from heterologous SARS CoV 2 and H5N1 influenza virus challenges; Dr. Ebony Gary, The Wistar Institute
TITLE: Industry Session: Computational Vaccinology; Dr. Annie De Groot, EpiVax
